Author:
Mohd Abd Razak Mohd Ridzuan,Md Jelas Nur Hana,Norahmad Nor Azrina,Mohmad Misnan Norazlan,Muhammad Amirrudin,Padlan Noorsofiana,Sa’at Muhammad Nor Farhan,Zainol Murizal,Syed Mohamed Ami Fazlin
Funder
Ministry of Health Malaysia
Publisher
Springer Science and Business Media LLC
Reference76 articles.
1. WHO. WHO Coronavirus (COVID-19.) Dashboard 2024 [updated 5 May 2024. https://covid19.who.int
2. Mugglestone MA, Ratnaraja NV, Bak A, Islam J, Wilson JA, Bostock J, et al. Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance. BMC Infect Dis. 2022;22(1):453.
3. NIH. Clinical Spectrum of SARS-CoV-2 Infection 2023 [updated 6 March 2023. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/
4. Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and Mortality. Clin Rev Allergy Immunol. 2023;64(1):90–107.
5. Al-Awaida J, Jawabrah Al Hourani W, Swedan B, Nimer S, Alzoughool R, Al-Ameer FJ. H, Correlates of SARS-CoV-2 variants on deaths, Case Incidence and Case Fatality ratio among the continents for the period of 1 December 2020 to 15 March 2021. Genes [Internet]. 2021; 12(7).